Resultado de búsqueda
JDRF is the world’s largest nonprofit funder of type 1 diabetes (T1D) research, aiming to cure, treat and prevent the disease. Learn about T1D symptoms, management, events, resources, advocacy and more.
- My Events / Fundraisers
Toggle Search Toggle Navigation Menu Toggle Navigation Menu....
- Our Impact
In fiscal year 2023, we drew $311M in additional funding and...
- Community
Now more than ever, we need to stay connected as a community...
- Calendar
Stay connected and safe while staying up-to-date on research...
- Fundraising
JDRF fundraising supports critical research in supporting...
- My Account
Please contact your JDRF staff partner for any assistance in...
- Research
Investing in research and clinical trials aimed at...
- Clinical Trials
For a treatment, drug, or device to make it into the hands...
- My Events / Fundraisers
JDRF is the leading global organization funding type 1 diabetes (T1D) research, with a vision of a world without T1D. Learn about the disease, its complications, and how JDRF works to cure, prevent and treat it through research, advocacy and education.
JDRF UK is a charity that funds research to cure, treat and prevent type 1 diabetes and its complications. It also provides information, advice and events for people living with type 1 and their families.
Juvenile Diabetes Research Foundation JDRF is a nonprofit 501(c)(3) organization that funds type 1 diabetes (T1D) research, provides a broad array of community and activist services to the T1D population and actively advocates for regulation favorable to medical research and approval of new and improved treatment modalities.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D. Vision: A world without type 1 diabetes Mission: Accelerating life-changing breakthroughs to cure, prevent and treat T1D and its complications
About JDRF. JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our strength lies in our exclusive focus and singular influence on the worldwide effort to end T1D.
